# The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels

> **NCT07057414** · PHASE2 · RECRUITING · sponsor: **Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.** · enrollment: 11 (estimated)

## Conditions studied

- Cadmium Exceeds the Standard

## Interventions

- **DRUG:** GMDTC for injection
- **OTHER:** 0.9% Sodium Chloride Injection(0.9% NaCl)

## Key facts

- **NCT ID:** NCT07057414
- **Lead sponsor:** Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-07
- **Primary completion:** 2025-10-29
- **Final completion:** 2025-12-30
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07057414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07057414, "The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07057414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*